| Phase 2 |
| NCT06145633 |
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic… |
Castration-Resistant Prostate Carcinoma |
Recruiting |
| NCT02559778 |
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy |
Neuroblastoma |
Recruiting |
| NCT00616967 |
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly… |
Breast Cancer |
Active, Not Recruiting |
| NCT01587352 |
Vorinostat in Treating Patients With Metastatic Melanoma of the Eye |
Metastatic Uveal Melanoma |
Active, Not Recruiting |
| NCT06995521 |
Vorinostat for Graft-versus-host Disease (GVHD) Prevention in Non-Malignant Adolescent… |
GVHD |
Not Yet Recruiting |
| NCT01522976 |
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With… |
Chronic Myelomonocytic Leukemia |
Active, Not Recruiting |
| Phase 1/2 |
| NCT03167437 |
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of… |
Crohn's Disease |
Recruiting |
| NCT05848687 |
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II |
Lymphoblastic Leukemia |
Recruiting |
| NCT03842696 |
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults… |
Hematologic Diseases |
Active, Not Recruiting |
| NCT00392353 |
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute… |
Acute Erythroid Leukemia |
Active, Not Recruiting |
| NCT00972478 |
Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly… |
Ann Arbor Stage II Non-Hodgkin Lymphoma |
Active, Not Recruiting |
| Phase 1 |
| NCT05317403 |
Venetoclax to Augment Epigenetic Modification and Chemotherapy |
Acute Myeloid Leukemia, in Relapse |
Recruiting |
| NCT04308330 |
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS… |
Ewing Sarcoma |
Recruiting |
| NCT07150013 |
Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat… |
Rett Syndrome |
Recruiting |
| NCT07150026 |
An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Pitt Hopkins… |
Pitt Hopkins Syndrome |
Recruiting |
| NCT01087554 |
Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer |
Advanced Cancer |
Active, Not Recruiting |
| NCT03742245 |
Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or… |
Breast Cancer Metastatic |
Active, Not Recruiting |
| NCT00336063 |
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic… |
Adult Nasal Type Extranodal NK/T-Cell Lymphoma |
Active, Not Recruiting |
| NCT01281176 |
High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in… |
Adult Solid Neoplasm |
Active, Not Recruiting |
| NCT00268385 |
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas |
Adult Anaplastic Astrocytoma |
Active, Not Recruiting |